In a first step, we examined the expression of TRAIL-R1 and -R2 and FAS in our panel of NPC cell lines, C17-PDX cells and the nasoepithelial cell line NP69 using flow cytometry. This evidence concerns the gene FAS and nasopharyngeal carcinoma.